DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Dolastatin 10 is an investigational drug.
There have been 7 clinical trials for Dolastatin 10. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 1999.
The most common disease conditions in clinical trials are Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell, and Gallbladder Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), M.D. Anderson Cancer Center, and University of Chicago.
Recent Clinical Trials for Dolastatin 10
|Dolastatin 10 in Treating Patients With Advanced Kidney Cancer||National Cancer Institute (NCI)||Phase 2|
|Dolastatin 10 in Treating Patients With Advanced Kidney Cancer||Mayo Clinic||Phase 2|
|Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma||National Cancer Institute (NCI)||Phase 2|